PO.PR01.05 · 预防研究

Novel application of the iCCaRE consortium virtual reality assistant (ViRA) to support Black men at the point of prostate cancer diagnosis

海报缩略图:Novel application of the iCCaRE consortium virtual reality assistant (ViRA) to support Black men at the point of prostate cancer diagnosis
编号 6306 展板 7 时间 4/21 02:00–05:00 区域 Section 35 主讲 Folakemi Odedina, PhD
分会场 Advances in Survivorship
查看完整资料 下载 PDF 登录后可访问当前开放资料 AACR 官方页面 ↗

作者与单位

Folakemi T. Odedina1, Che Ngufor2, Christopher Williams3, Mary Ellen Young4, Floyd Willis5, Adam M. Kase1, Arnold Merriweather6, Emelina Asto-Flores1, Dee M. Glaser-Boivin5, Jada Melton1, Monica L. Albertie7, Michelle Fudge1, Quincy Wimberly1, Inclusive Cancer Care Research Equity (iCCaRE) Consortium, Prostate Cancer Transatlantic Consortium (CaPTC)

1Mayo Clinic Florida, Jacksonville, FL,2Mayo Clinic, Rochester, MN,3Urological Assoc Inc, Jacksonville, FL,4University of Florida College of Public Health & Health Professions, Gainesville, FL,5Mayo Clinic, Jacksonville, FL,6Black Male Prostate Coalition of Florida, Jacksonville, FL,7Cancer Services, Mayo Clinic, Jacksonville, FL

摘要 Abstract

Background: Black men carry a disproportionate prostate cancer (CaP) burden and often experience significant psychosocial distress at the point of prostate cancer diagnosis (PPCD). Many report emotional shock, uncertainty, and limited access to culturally competent guidance, which can negatively affect treatment decisions and long-term survivorship. To address these needs, we developed the PPCD Virtual Reality Assistant (ViRA), an immersive, AI-enabled intervention co-designed with Black CaP survivors. ViRA delivers tailored psycho-oncology support, emotional guidance, and navigation of social determinants of health (SDOH) within virtual reality environments. This study evaluated the feasibility, acceptability, and usability of the PPCD ViRA (NCT06535802). Methods: ViRA was developed through a structured, seven-step co-design process with survivors, integrating mobile immersive technologies, SDOH navigation, and culturally grounded psycho-oncology content. Personalization was enabled through AI-driven predictive analytics and a recommendation engine. Alpha testing assessed initial usability and acceptability among 10 participants (seven team members and three Black CaP survivors). Beta testing with 24 Black men in Florida examined feasibility and preliminary efficacy. Results: A demonstration of ViRA is available (https://www.youtube.com/watch?v=1mI-HS5R6sk). Alpha testing indicated strong usability, positive emotional engagement, and clear promise for enhancing support at the PPCD. In Beta testing, participants varied in age; most were married (58.3%), held a bachelor's degree (45.8%), were retired (45.8%), and had a family history of cancer (83.3%). ViRA use was associated with increased engagement and reduced distress across participants. Overall, 74% rated ViRA as “excellent,” while the remainder rated it as “good” or “very good.” More than 90% reported being “very satisfied,” with the rest indicating satisfaction. Conclusions: Findings demonstrate high feasibility, acceptability, and cultural relevance of the PPCD ViRA for supporting Black men at diagnosis. Lessons learned highlight the need for culturally embedded design, emotional timing, community co-creation, flexible delivery formats, and strong community partnerships to advance digital health equity. The refinement and larger-scale validation to establish clinical utility and readiness for implementation is ongoing (NCT07126548).
利益披露 Disclosure
F. T. Odedina, None.. C. Williams, None.. J. Melton, None.. M. Fudge, None.. Q. Wimberly, None.

在会议检索中打开